首页|期刊导航|中国体外生命支持|高出血风险维持性血液透析患者不同抗凝策略对体外循环凝血及出血事件的影响

高出血风险维持性血液透析患者不同抗凝策略对体外循环凝血及出血事件的影响OA

Impact of Different Anticoagulation Strategies on Extracorporeal Circuit Clotting and Bleeding Events in Maintenance Hemodialysis Patients at High Risk of Bleeding

中文摘要英文摘要

目的 探讨高出血风险维持性血液透析患者应用不同体外循环抗凝策略时的凝血控制效果及出血安全性,为个体化抗凝方案选择提供依据.方法 采用前瞻性队列研究设计,纳入2022年1月至2025年1月本院接受维持性血液透析并符合高出血风险标准的患者62例,按透析抗凝策略分为无肝素组21例、低剂量低分子肝素组20例和局部枸橼酸抗凝(RCA)组21例.比较三组体外循环压力变化、透析器凝血评分、透析器提前凝血、凝血激活指标及出血事件.结果 三组基线资料差异均无统计学意义(均P>0.05).RCA组跨膜压(TMP)升幅低于低剂量低分子肝素组和无肝素组[(18.7±6.4)mmHg vs.(27.9±9.7)mmHg、(41.3±12.8)mmHg,P<0.001].无肝素组、低剂量低分子肝素组、RCA组透析器提前凝血发生率分别为38.10%(8/21)、20.00%(4/20)和9.52%(2/21),呈递减趋势(P=0.027).透析后血栓调节蛋白、纤溶酶-α2纤溶酶抑制剂复合物、凝血酶-抗凝血酶复合物及组织型纤溶酶原激活物-纤溶酶原激活物抑制剂复合物水平均呈RCA组最低、低剂量低分子肝素组居中、无肝素组最高的趋势,组间比较差异均有统计学意义(均P<0.05).共发生出血事件16例(25.81%),其中主要出血5例(8.06%)、临床相关非大出血(CRNMB)8例(12.90%)、轻微出血3例(4.84%);主要出血组间差异无统计学意义(P=0.829),CRNMB发生率在无肝素组、低剂量低分子肝素组和RCA组分别为23.81%、15.00%和0,呈下降趋势(P=0.021).多因素Logistic回归分析显示,无肝素策略(OR=2.88,95%CI:1.11~7.43,P=0.029)和TMP升幅(OR=1.07,95%CI:1.02~1.13,P=0.008)是透析器提前凝血的独立相关因素.Kaplan-Meier分析显示,RCA组透析器维持通畅时间最长(P=0.014).结论 对高出血风险维持性血液透析患者,RCA较无肝素和低剂量低分子肝素更有利于维持体外循环通畅、减轻TMP升高并降低透析器提前凝血发生风险,且未增加主要出血事件.无肝素策略虽可避免系统性抗凝暴露,但凝血风险较高;低剂量低分子肝素的安全性与有效性居中.RCA可作为此类患者较为安全、有效的个体化抗凝选择.

Objective To evaluate the effects of different extracorporeal anticoagulation strategies on circuit clotting control and bleeding safety in maintenance hemodialysis patients at high risk of bleeding,and to provide evidence for individu-alized anticoagulation management.Methods This prospective cohort study enrolled 62 maintenance hemodialysis patients at high bleeding risk from January 2022 to January 2025.According to the anticoagulation strategy used during dialysis,patients were assigned to a heparin-free group(n=21),a low-dose low-molecular-weight heparin(LMWH)group(n=20),and a region-al citrate anticoagulation(RCA)group(n=21).Changes in extracorporeal circuit pressure,dialyzer clotting grade,premature circuit clotting,coagulation activation biomarkers,and bleeding events were compared among the three groups.Results Base-line characteristics were comparable among the three groups(all P>0.05).The increase in transmembrane pressure(TMP)was significantly lower in the RCA group than in the low-dose LMWH and heparin-free groups[(18.7±6.4)mmHg vs.(27.9±9.7)mmHg and(41.3±12.8)mmHg,P<0.001].The incidence of premature circuit clotting decreased from the heparin-free group to the low-dose LMWH group and RCA group[38.10%(8/21),20.00%(4/20),and 9.52%(2/21),respectively;P=0.027 for trend].Post-dialysis levels of thrombomodulin,plasmin-α2-plasmin inhibitor complex,thrombin-antithrombin complex,and tissue-type plasminogen activator-inhibitor complex showed a graded pattern,with the lowest levels in the RCA group,intermediate levels in the low-dose LMWH group,and the highest levels in the heparin-free group,and the between-group differences were statis-tically significant(all P<0.05).A total of 16 bleeding events occurred,including 5 major bleeding events(8.06%),8 clinically relevant non-major bleeding(CRNMB)events(12.90%),and 3 minor bleeding events(4.84%).The rate of major bleeding did not differ significantly among the groups(P=0.829),whereas the incidence of CRNMB decreased from the heparin-free group to the low-dose LMWH group and RCA group(23.81%,15.00%,and 0%,respectively;P=0.021 for trend).Multivariate logistic regression showed that heparin-free dialysis(OR=2.88,95%CI:1.11-7.43,P=0.029)and TMP elevation(OR=1.07,95%CI:1.02-1.13,P=0.008)were independently associated with premature circuit clotting.Kaplan-Meier analysis indicated that the RCA group had the longest circuit patency time(P=0.014).Conclusion In maintenance hemodialysis patients at high risk of bleeding,RCA was more effective than heparin-free dialysis and low-dose LMWH in maintaining extracorporeal circuit patency,attenuating TMP elevation,and reducing premature circuit clotting,without increasing major bleeding events.Heparin-free dial-ysis avoided systemic anticoagulant exposure but was associated with a higher risk of circuit clotting,whereas low-dose LMWH showed an intermediate efficacy-safety profile.RCA may represent a safe and effective individualized anticoagulation strategy for this high-risk population.

刘文琴;曹钰琴;雷丽;邹勤;王明初

泸州市人民医院肾内科,四川 泸州 646000泸州市人民医院肾内科,四川 泸州 646000泸州市人民医院肾内科,四川 泸州 646000泸州市人民医院肾内科,四川 泸州 646000泸州市人民医院肾内科,四川 泸州 646000

高出血风险维持性血液透析体外循环局部枸橼酸抗凝凝血状态出血事件

high bleeding riskmaintenance hemodialysisextracorporeal circulationregional citrate anticoagulationcoagulation statusbleeding events

《中国体外生命支持》 2026 (4)

313-320,8

10.13498/j.cnki.chin.j.ecls.2026.04.08

评论